Ledger.Open graph →
SEC Form D · Amendment · filed July 8, 2011

SpringLeaf Therapeutics, Inc

Offering
$19.0M
Sold
$19.0M
Exemption
—
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

People & firms on this filing (18)

Frank Bobe · Boston, MAExec · DirectorGlenn Larsen · Boston, MAExecJeffrey Mccarthy · Boston, MADirectorMichael Cima · Boston, MADirectorYet-Ming Chiang · Boston, MADirectorKurt Graves · Boston, MADirectorGaren Bohlin · Boston, MADirectorMichael Greeley · Boston, MADirectorBrian Gallagher · Dublin, IrelandDirectorRobin K. Bacon · Petaluma, CAExec · DirectorMatthew G. Duffy · Petaluma, CADirectorGarrett Bernstein · Petaluma, CADirectorElizabeth A. Pearce · Petaluma, CADirectorLarry L. Faydo · San Diego, CADirectorJack Vanderknyff · Oceanside, CADirectorDaniel Holland · Hingham, MADirectorPatrick Rivelli · Marco Island, FLExecBrian Gallagher · Simsbury, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗